Design |
Randomized, double‐blind, placebo‐controlled |
Randomized, double‐blind, placebo‐controlled |
Randomized, double‐blind, placebo‐controlled |
Randomized, double‐blind, placebo‐controlled |
Randomized, double‐blind, active‐controlled |
Randomized, double‐blind, placebo‐controlled |
Randomized, controlled |
Randomized, placebo controlled |
Randomized, double‐blind, placebo‐controlled |
Primary endpoint |
Proportion of patients who converted to NSR within 30 min |
Proportion of patients who converted to NSR within 90 min |
Proportion of patients who converted to NSR within 90 min |
Proportion of patients who converted to NSR within 90 min |
Proportion of patients who converted to NSR within 90 min |
Proportion of patients who converted to NSR within 90 min |
Time to conversion of atrial fibrillation to NSR |
Proportion of patients who converted to NSR within 90 min |
Proportion of patients who converted to NSR within 90 min |